RecruitingPhase 3NCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Sponsor: Eli Lilly and Company
New York, NY · Yonkers, NY · +33 more sites
2 recruiting crohn's disease studies with a site in Yonkers, NY.
Sponsor: Eli Lilly and Company
New York, NY · Yonkers, NY · +33 more sites
Sponsor: AbbVie
Lake Success, NY · New York, NY · +61 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.